PAM
ADVM

Panagora Asset Management’s Adverum Biotechnologies ADVM Stock Holding History

Panagora Asset Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-988
Closed -$52K – 2402
2018
Q2 		$52K Buy
988
+222
+29% +$13.3K ﹤0.01% 2026
2018
Q1 		$44K Sell
766
-8,254
-92% -$514K ﹤0.01% 2070
2017
Q4 		$316K Buy
9,020
+531
+6% +$17.5K ﹤0.01% 1510
2017
Q3 		$310K Sell
8,489
-2,361
-22% -$65.5K ﹤0.01% 1517
2017
Q2 		$271K Sell
10,850
-18,808
-63% -$514K ﹤0.01% 1536
2017
Q1 		$801K Buy
29,658
+11,291
+61% +$321K ﹤0.01% 1227
2016
Q4 		$533K Sell
18,367
-1,540
-8% -$50.3K ﹤0.01% 1415
2016
Q3 		$818K Sell
19,907
-1,109
-5% -$42.1K ﹤0.01% 1265
2016
Q2 		$664K Buy
21,016
+924
+5% +$41.7K ﹤0.01% 1269
2016
Q1 		$1.04M Buy
20,092
+5,026
+33% +$281K 0.01% 1087
2015
Q4 		$1.43M Buy
15,066
+8,635
+134% +$759K 0.01% 931
2015
Q3 		$530K Buy
6,431
+6,081
+1,737% +$777K ﹤0.01% 1297
2015
Q2 		$57K Buy
+350
New +$118K ﹤0.01% 2106
2015
Q1 		– Sell
-1,888
Closed -$1.02M – 2325
2014
Q4 		$1.02M Sell
1,888
-563
-23% -$217K 0.01% 1040
2014
Q3 		$838K Buy
+2,451
New +$729K ﹤0.01% 1120

Other funds holding ADVM

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

Panagora Asset Management's ADVM Position: Q3 2018 in Review

Panagora Asset Management sold out of Adverum Biotechnologies (ADVM) in Q3 2018, closing a stake of 988 shares — an estimated $52K sold.

Panagora Asset Management first reported a position in ADVM in Q3 2014 and held it in 15 quarters. The position peaked at $1.43M in Q4 2015. 101 funds tracked by Wall St. Rank hold ADVM as of Q3 2018.

  • Panagora Asset Management reported no remaining Adverum Biotechnologies position as of Q3 2018 after selling out during the quarter.
  • Panagora Asset Management sold 988 Adverum Biotechnologies shares in Q3 2018, an estimated $52K.
  • Panagora Asset Management first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 15 quarters.
  • Panagora Asset Management's Adverum Biotechnologies position peaked at $1.43M in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2018.

Based on Panagora Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.